Issue Date | Title | Author(s) |
2019 | ALBUMIN AND PLATELET AFTER SIX MONTHS OF ANTIVIRAL THERAPY ARE INDEPENDENT SERUM MARKERS TO PREDICT LIVER RELATED EVENTS IN HBV-RELATED COMPENSATED LIVER CIRRHOSIS | Wu, Xiaoning; Zhou, Jialing; Meng, Tongtong; Sun, Yameng; Wang, Bingqiong; Piao, Hongxin; Ding, Huiguo; Xu, Xiaoyuan; Jiang, Wei; Chen, Yongpeng; Xie, Wen; Ma, Anlin; Cheng, Jun, Sr.; Cheng, Jilin; Zhang, Mingxiang; Guan, Qiushuang; Chen, Shuyan; Shi, Yiwen; Duan, Weijia; Kong, Yuanyuan; Ou, Xiaojuan; You, Hong; Jia, Jidong |
Oct-2020 | Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks | Wang, Xiaomei; Wang, Zhongfeng; Chi, Xiumei; Wu, Ruihong; Jin, Qinglong; Xu, Hongqin; Gao, Xiuzhu; Yu, Lei; Chen, Yuping; Shang, Jia; Liu, Longgen; Zhang, Shuqin; Jiang, Yongfang; Zhang, Mingxiang; Tong, Qiaoxia; Zhang, Lunli; Tan, Youwen; Ma, Anlin; Dang, Shuangsuo; Xu, Bin; Jin, Zhenjing; Li, Jia; Li, Xiaobo; Lu, Fengmin; Niu, Junqi |
2019 | Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study | Wu, Xiaoning; Zhou, Jialing; Xie, Wen; Ding, Huiguo; Ou, Xiaojuan; Chen, Guofeng; Ma, Anlin; Xu, Xiaoyuan; Ma, Hui; Xu, Youqing; Liu, Xiaoqing; Meng, Tongtong; Wang, Lin; Sun, Yameng; Wang, Bingqiong; Kong, Yuanyuan; Ma, Hong; You, Hong; Jia, Jidong |
Jul-2021 | HBeAg-positive patients with HBsAg < 100 IU/mL and negative HBV RNA have lower risk of virological relapse after nucleos(t)ide analogues cessation | Xie, Yandi; Li, Minghui; Ou, Xiaojuan; Zheng, Sujun; Gao, Yinjie; Xu, Xiaoyuan; Yang, Ying; Ma, Anlin; Li, Jia; Huang, Yuan; Nan, Yuemin; Zheng, Huanwei; Feng, Bo |
Oct-2021 | HBEAG-POSITIVE PATIENTS WITH HBsAg < 100 IU/ML AND NEGATIVE HBV RNA HAVE LOWER RISK OF VIROLOGICAL RELAPSE AFTER NUCLEOS(T)IDE ANALOGUES CESSATION | Xie, Yandi; Li, Minghui; Ou, Xiaojuan; Zheng, Sujun; Gao, Yinjie; Xu, Xiaoyuan; Yang, Ying; Ma, Anlin; Li, Jia; Huang, Yuan; Nan, Yuemin; Zheng, Huanwei; Feng, Bo |
2019 | HEALTH RELATED QUALITY OF LIFE (HRQoL) IN COMPENSATED HBV-INDUCED LIVER CIRRHOSIS PATIENTS SIGNIFICANTLY IMPROVED AFTER ANTIVIRAL THERAPY | Hong, Jia; Wu, Xiaoning; Zhou, Jialing; Meng, Tongtong; Guan, Qiushuang; Piao, Hongxin; Feng, Bo; Jiang, Wei; Lu, Lungen; Chen, Yongpeng; Xie, Wen; Xu, Youqing; Huo, Lijuan; Zhang, Xuqing; Shang, Jia; Ma, Anlin; Cheng, Jilin; Han, Tao; Zou, Zhiqiang; Duan, Weijia; Wu, Shanshan; Kong, Yuanyuan; Ou, Xiaojuan; Jia, Jidong; You, Hong |
Jun-2023 | IP10 and anti-HBc can predict virological relapase and HBsAg loss for chronic hepatitis B patients after nucleos (t)ide analogue discontinuation | Xie, Yandi; Li, Minghui; Ou, Xiaojuan; Zheng, Sujun; Gao, Yinjie; Xu, Xiaoyuan; Yang, Ying; Ma, Anlin; Li, Jia; Nan, Yuemin; Zheng, Huanwei; Liu, Juan; Wei, Lai; Feng, Bo |
2023 | IP10 and anti-HBc can predict virological relapse and HBsAg loss in chronic hepatitis B patients after nucleos(t)ide analogue discontinuation | Xie, Yandi; Li, Minghui; Ou, Xiaojuan; Zheng, Sujun; Gao, Yinjie; Xu, Xiaoyuan; Yang, Ying; Ma, Anlin; Li, Jia; Nan, Yuemin; Zheng, Huanwei; Liu, Juan; Wei, Lai; Feng, Bo |
29-Jun-2023 | Lower end of treatment HBsAg and HBcrAg were associated with HBsAg loss after nucleos(t)ide analog cessation | Xie, Yandi; Li, Minghui; Ou, Xiaojuan; Zheng, Sujun; Gao, Yinjie; Xu, Xiaoyuan; Yang, Ying; Ma, Anlin; Li, Jia; Nan, Yuemin; Zheng, Huanwei; Liu, Juan; Wei, Lai; Feng, Bo |
29-Jun-2023 | Lower end of treatment HBsAg and HBcrAg were associated with HBsAg loss after nucleos(t)ide analog cessation | Xie, Yandi; Li, Minghui; Ou, Xiaojuan; Zheng, Sujun; Gao, Yinjie; Xu, Xiaoyuan; Yang, Ying; Ma, Anlin; Li, Jia; Nan, Yuemin; Zheng, Huanwei; Liu, Juan; Wei, Lai; Feng, Bo |
Mar-2022 | New geochemical constraints on the development of active continental margin in Southeast China during the Middle Permian and its tectonic implications | Zhang, Bolin; Yao, Suping; Ma, Anlin; Hu, Wenxuan; Liu, Biao; Yang, Wenguang |
2017 | Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase | Zhou, Jiyuan; Song, Liuwei; Zhao, Hong; Yan, Linlin; Ma, Anlin; Xie, Shibin; Zhang, Xuqing; Zhang, Dazhi; Xie, Qing; Zhang, Guo; Shang, Jia; Cheng, Jun; Zhao, Weifeng; Zou, Zhiqiang; Zhang, Mingxiang; Xia, Ningshao; Wang, Guiqiang |